Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-007968
Filing Date
2023-03-15
Accepted
2023-03-15 09:21:21
Documents
2
Period of Report
2023-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167888646953394.html 4  
1 FORM 4 wf-form4_167888646953394.xml 4 5764
2 HALLADAY POA ex-24.htm EX-24 3972
  Complete submission text file 0001628280-23-007968.txt   11225
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address
Halladay Benjamin (Reporting) CIK: 0001953943 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 23733510